| Identification | Back Directory | [Name]
4-Quinazolinamine, 2-(7-methylimidazo[1,2-a]pyridin-6-yl)-N-[2-phenyl-2-(1H-pyrrol-2-yl)ethyl]- | [CAS]
1928715-72-3 | [Synonyms]
SRI-31040
4-Quinazolinamine, 2-(7-methylimidazo[1,2-a]pyridin-6-yl)-N-[2-phenyl-2-(1H-pyrrol-2-yl)ethyl]- | [Molecular Formula]
C28H24N6 | [MOL File]
1928715-72-3.mol | [Molecular Weight]
444.53 |
| Hazard Information | Back Directory | [Description]
SRI-31040 is a potent DAT allosteric modulator. SRI-31040 partially inhibits DAT uptake without altering DAT-mediated reverse transport and with minimal inhibition of DAT binding. | [Uses]
SRI-31040 is an active compound. | [References]
[1] Studies of the biogenic amine transporters 15. Identification of novel allosteric dopamine transporter ligands with nanomolar potency |
|
|